2/23
08:00 am
pths
Pelthos Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Medium
Report
Pelthos Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
1/13
08:30 am
pths
Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance
Low
Report
Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance
1/5
07:37 am
pths
Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice [Yahoo! Finance]
Low
Report
Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice [Yahoo! Finance]
1/5
07:30 am
pths
Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice
Low
Report
Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice
12/23
05:57 pm
pths
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn
Low
Report
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn
12/10
03:50 am
pths
Ligand Pharmaceuticals Incorporated (LGND) Analyst/Investor Day Transcript [Seeking Alpha]
Low
Report
Ligand Pharmaceuticals Incorporated (LGND) Analyst/Investor Day Transcript [Seeking Alpha]